1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Nephrology Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 ACE Inhibitors
        1.2.3 Calcium Channel Blocker
        1.2.4 Beta Blockers
        1.2.5 Diuretics
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Nephrology Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Pharmacy
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Nephrology Drugs Market Perspective (2017-2028)
    2.2 Nephrology Drugs Growth Trends by Region
        2.2.1 Nephrology Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Nephrology Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Nephrology Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Nephrology Drugs Market Dynamics
        2.3.1 Nephrology Drugs Industry Trends
        2.3.2 Nephrology Drugs Market Drivers
        2.3.3 Nephrology Drugs Market Challenges
        2.3.4 Nephrology Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Nephrology Drugs Players by Revenue
        3.1.1 Global Top Nephrology Drugs Players by Revenue (2017-2022)
        3.1.2 Global Nephrology Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Nephrology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Nephrology Drugs Revenue
    3.4 Global Nephrology Drugs Market Concentration Ratio
        3.4.1 Global Nephrology Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Nephrology Drugs Revenue in 2021
    3.5 Nephrology Drugs Key Players Head office and Area Served
    3.6 Key Players Nephrology Drugs Product Solution and Service
    3.7 Date of Enter into Nephrology Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Nephrology Drugs Breakdown Data by Type
    4.1 Global Nephrology Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Nephrology Drugs Forecasted Market Size by Type (2023-2028)
5 Nephrology Drugs Breakdown Data by Application
    5.1 Global Nephrology Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Nephrology Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Nephrology Drugs Market Size (2017-2028)
    6.2 North America Nephrology Drugs Market Size by Country (2017-2022)
    6.3 North America Nephrology Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Nephrology Drugs Market Size (2017-2028)
    7.2 Europe Nephrology Drugs Market Size by Country (2017-2022)
    7.3 Europe Nephrology Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Nephrology Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Nephrology Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Nephrology Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Nephrology Drugs Market Size (2017-2028)
    9.2 Latin America Nephrology Drugs Market Size by Country (2017-2022)
    9.3 Latin America Nephrology Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Nephrology Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Nephrology Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Nephrology Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Detail
        11.1.2 AstraZeneca Business Overview
        11.1.3 AstraZeneca Nephrology Drugs Introduction
        11.1.4 AstraZeneca Revenue in Nephrology Drugs Business (2017-2022)
        11.1.5 AstraZeneca Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Detail
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Nephrology Drugs Introduction
        11.2.4 Pfizer Revenue in Nephrology Drugs Business (2017-2022)
        11.2.5 Pfizer Recent Development
    11.3 Amgen
        11.3.1 Amgen Company Detail
        11.3.2 Amgen Business Overview
        11.3.3 Amgen Nephrology Drugs Introduction
        11.3.4 Amgen Revenue in Nephrology Drugs Business (2017-2022)
        11.3.5 Amgen Recent Development
    11.4 FibroGen
        11.4.1 FibroGen Company Detail
        11.4.2 FibroGen Business Overview
        11.4.3 FibroGen Nephrology Drugs Introduction
        11.4.4 FibroGen Revenue in Nephrology Drugs Business (2017-2022)
        11.4.5 FibroGen Recent Development
    11.5 GlaxoSmithkline
        11.5.1 GlaxoSmithkline Company Detail
        11.5.2 GlaxoSmithkline Business Overview
        11.5.3 GlaxoSmithkline Nephrology Drugs Introduction
        11.5.4 GlaxoSmithkline Revenue in Nephrology Drugs Business (2017-2022)
        11.5.5 GlaxoSmithkline Recent Development
    11.6 AbbVie
        11.6.1 AbbVie Company Detail
        11.6.2 AbbVie Business Overview
        11.6.3 AbbVie Nephrology Drugs Introduction
        11.6.4 AbbVie Revenue in Nephrology Drugs Business (2017-2022)
        11.6.5 AbbVie Recent Development
    11.7 Akebia Therapeutics
        11.7.1 Akebia Therapeutics Company Detail
        11.7.2 Akebia Therapeutics Business Overview
        11.7.3 Akebia Therapeutics Nephrology Drugs Introduction
        11.7.4 Akebia Therapeutics Revenue in Nephrology Drugs Business (2017-2022)
        11.7.5 Akebia Therapeutics Recent Development
    11.8 Teva Pharmaceutical Industries
        11.8.1 Teva Pharmaceutical Industries Company Detail
        11.8.2 Teva Pharmaceutical Industries Business Overview
        11.8.3 Teva Pharmaceutical Industries Nephrology Drugs Introduction
        11.8.4 Teva Pharmaceutical Industries Revenue in Nephrology Drugs Business (2017-2022)
        11.8.5 Teva Pharmaceutical Industries Recent Development
    11.9 Johnson & Johnson
        11.9.1 Johnson & Johnson Company Detail
        11.9.2 Johnson & Johnson Business Overview
        11.9.3 Johnson & Johnson Nephrology Drugs Introduction
        11.9.4 Johnson & Johnson Revenue in Nephrology Drugs Business (2017-2022)
        11.9.5 Johnson & Johnson Recent Development
    11.10 Roche
        11.10.1 Roche Company Detail
        11.10.2 Roche Business Overview
        11.10.3 Roche Nephrology Drugs Introduction
        11.10.4 Roche Revenue in Nephrology Drugs Business (2017-2022)
        11.10.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
                  
              

                

                 
List of Tables
    Table 1. Global Nephrology Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of ACE Inhibitors
    Table 3. Key Players of Calcium Channel Blocker
    Table 4. Key Players of Beta Blockers
    Table 5. Key Players of Diuretics
    Table 6. Key Players of Others
    Table 7. Global Nephrology Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Nephrology Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Nephrology Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Nephrology Drugs Market Share by Region (2017-2022)
    Table 11. Global Nephrology Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Nephrology Drugs Market Share by Region (2023-2028)
    Table 13. Nephrology Drugs Market Trends
    Table 14. Nephrology Drugs Market Drivers
    Table 15. Nephrology Drugs Market Challenges
    Table 16. Nephrology Drugs Market Restraints
    Table 17. Global Nephrology Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Nephrology Drugs Market Share by Players (2017-2022)
    Table 19. Global Top Nephrology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nephrology Drugs as of 2021)
    Table 20. Ranking of Global Top Nephrology Drugs Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Nephrology Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Nephrology Drugs Product Solution and Service
    Table 24. Date of Enter into Nephrology Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Nephrology Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Nephrology Drugs Revenue Market Share by Type (2017-2022)
    Table 28. Global Nephrology Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Nephrology Drugs Revenue Market Share by Type (2023-2028)
    Table 30. Global Nephrology Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Nephrology Drugs Revenue Market Share by Application (2017-2022)
    Table 32. Global Nephrology Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Nephrology Drugs Revenue Market Share by Application (2023-2028)
    Table 34. North America Nephrology Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Nephrology Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Nephrology Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Nephrology Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Nephrology Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Nephrology Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Nephrology Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Nephrology Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Nephrology Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Nephrology Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 44. AstraZeneca Company Detail
    Table 45. AstraZeneca Business Overview
    Table 46. AstraZeneca Nephrology Drugs Product
    Table 47. AstraZeneca Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
    Table 48. AstraZeneca Recent Development
    Table 49. Pfizer Company Detail
    Table 50. Pfizer Business Overview
    Table 51. Pfizer Nephrology Drugs Product
    Table 52. Pfizer Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
    Table 53. Pfizer Recent Development
    Table 54. Amgen Company Detail
    Table 55. Amgen Business Overview
    Table 56. Amgen Nephrology Drugs Product
    Table 57. Amgen Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
    Table 58. Amgen Recent Development
    Table 59. FibroGen Company Detail
    Table 60. FibroGen Business Overview
    Table 61. FibroGen Nephrology Drugs Product
    Table 62. FibroGen Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
    Table 63. FibroGen Recent Development
    Table 64. GlaxoSmithkline Company Detail
    Table 65. GlaxoSmithkline Business Overview
    Table 66. GlaxoSmithkline Nephrology Drugs Product
    Table 67. GlaxoSmithkline Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
    Table 68. GlaxoSmithkline Recent Development
    Table 69. AbbVie Company Detail
    Table 70. AbbVie Business Overview
    Table 71. AbbVie Nephrology Drugs Product
    Table 72. AbbVie Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
    Table 73. AbbVie Recent Development
    Table 74. Akebia Therapeutics Company Detail
    Table 75. Akebia Therapeutics Business Overview
    Table 76. Akebia Therapeutics Nephrology Drugs Product
    Table 77. Akebia Therapeutics Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
    Table 78. Akebia Therapeutics Recent Development
    Table 79. Teva Pharmaceutical Industries Company Detail
    Table 80. Teva Pharmaceutical Industries Business Overview
    Table 81. Teva Pharmaceutical Industries Nephrology Drugs Product
    Table 82. Teva Pharmaceutical Industries Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
    Table 83. Teva Pharmaceutical Industries Recent Development
    Table 84. Johnson & Johnson Company Detail
    Table 85. Johnson & Johnson Business Overview
    Table 86. Johnson & Johnson Nephrology Drugs Product
    Table 87. Johnson & Johnson Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
    Table 88. Johnson & Johnson Recent Development
    Table 89. Roche Company Detail
    Table 90. Roche Business Overview
    Table 91. Roche Nephrology Drugs Product
    Table 92. Roche Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
    Table 93. Roche Recent Development
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Nephrology Drugs Market Share by Type: 2021 VS 2028
    Figure 2. ACE Inhibitors Features
    Figure 3. Calcium Channel Blocker Features
    Figure 4. Beta Blockers Features
    Figure 5. Diuretics Features
    Figure 6. Others Features
    Figure 7. Global Nephrology Drugs Market Share by Application in 2021 & 2028
    Figure 8. Hospital Pharmacy Case Studies
    Figure 9. Retail Pharmacy Case Studies
    Figure 10. Online Pharmacy Case Studies
    Figure 11. Nephrology Drugs Report Years Considered
    Figure 12. Global Nephrology Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Nephrology Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Nephrology Drugs Market Share by Region: 2021 VS 2028
    Figure 15. Global Nephrology Drugs Market Share by Players in 2021
    Figure 16. Global Top Nephrology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nephrology Drugs as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Nephrology Drugs Revenue in 2021
    Figure 18. North America Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Nephrology Drugs Market Share by Country (2017-2028)
    Figure 20. United States Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Nephrology Drugs Market Share by Country (2017-2028)
    Figure 24. Germany Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Nephrology Drugs Market Share by Region (2017-2028)
    Figure 32. China Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Nephrology Drugs Market Share by Country (2017-2028)
    Figure 40. Mexico Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Nephrology Drugs Market Share by Country (2017-2028)
    Figure 44. Turkey Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. AstraZeneca Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
    Figure 47. Pfizer Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
    Figure 48. Amgen Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
    Figure 49. FibroGen Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
    Figure 50. GlaxoSmithkline Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
    Figure 51. AbbVie Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
    Figure 52. Akebia Therapeutics Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
    Figure 53. Teva Pharmaceutical Industries Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
    Figure 54. Johnson & Johnson Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
    Figure 55. Roche Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed